State Of Wyoming Deciphera Pharmaceuticals, Inc. Transaction History

State Of Wyoming

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $2,341 - $3,592	-257 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$6.87 - $11.11 $4,946 - $7,999	-720 Reduced 73.69%	257 $2,000
Q4 2021 Feb 11, 2022	BUY	$7.7 - $37.13 $1,139 - $5,495	148 Added 17.85%	977 $10,000
Q3 2021 Feb 11, 2022	SELL	$26.46 - $37.15 $13,309 - $18,686	-503 Reduced 37.76%	829 $28,000
Q2 2021 Feb 11, 2022	BUY	$32.73 - $47.95 $26,020 - $38,120	795 Added 148.04%	1,332 $49,000
Q1 2021 Feb 08, 2022	BUY	$40.39 - $56.73 $21,689 - $30,464	537 New	537 $24,000

343K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.